![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Biochemistry and Pathology, Division of Cell Biology and Genetics, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada
Abstract
Vitamin A deficiency has been associated with increased incidence of certain types of cancer; however, the mechanisms by which vitamin A depletion promotes tumorigenesis are poorly understood. In addition all-trans-retinoic acid (RA), the most active form of vitamin A metabolites, has been shown to limit carcinogenesis in animal models and to trigger programmed cell death (apoptosis) in certain types of tumor cells. On the other hand, we show here that various cell lines overexpressing CYP26A1, a cytochrome P450 enzyme specifically involved in the catabolic inactivation of RA, exhibit increased resistance to various apoptogenic factors, including death receptor ligands such as tumor necrosis factor-related apoptosis-inducing ligand. This resistance could be reversed by pretreatment with ketoconazole, a broad-spectrum inhibitor of cytochrome P450 enzymes. In addition, synthetic retinoids Am80 (4[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid) and Am580 [4(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtamido)benzoic acid], which are resistant to CYP26A1 metabolism, can restore the sensitivity of these cells to apoptogens. Thus, these findings support the idea that CYP26 expression levels may play a role in determining cellular commitment to apoptosis, and increased RA metabolism may be at least partially responsible for these observed effects.
Address correspondence to: Dr. Martin Petkovich, Department of Biochemistry and Pathology, Division of Cell Biology and Genetics, Cancer Research Institute, 10 Stuart St., Queen's University, Kingston, ON, Canada K7L 3N6. E-mail: petkovic{at}post.queensu.ca
This article has been cited by other articles:
|
|
 |
|
  P. Ocaya, A. C. Gidlof, P. S. Olofsson, H. Torma, and A. Sirsjo CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Trasino, E. H. Harrison, and T. T. Y. Wang Androgen Regulation of Aldehyde Dehydrogenase 1A3 (ALDH1A3) in the Androgen-Responsive Human Prostate Cancer Cell Line LNCaP Experimental Biology and Medicine, June 1, 2007; 232(6): 762 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nishikiori, M. Osanai, H. Chiba, T. Kojima, H. Ohguro, and N. Sawada Inhibitory Effects of Retinoic Acid Receptor Alpha Stimulants on Murine Cataractogenesis through Suppression of Deregulated Calpains Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2224 - 2229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nishikiori, M. Osanai, H. Chiba, T. Kojima, Y. Mitamura, H. Ohguro, and N. Sawada Glial Cell-Derived Cytokines Attenuate the Breakdown of Vascular Integrity in Diabetic Retinopathy Diabetes, May 1, 2007; 56(5): 1333 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Jones, S. Dickerson, P. M. Bhende, H.-J. Delecluse, and S. C. Kenney Epstein-Barr Virus Lytic Infection Induces Retinoic Acid-responsive Genes through Induction of a Retinol-metabolizing Enzyme, DHRS9 J. Biol. Chem., March 16, 2007; 282(11): 8317 - 8324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Osanai, N. Nishikiori, M. Murata, H. Chiba, T. Kojima, and N. Sawada Cellular Retinoic Acid Bioavailability Determines Epithelial Integrity: Role of Retinoic Acid Receptor {alpha} Agonists in Colitis Mol. Pharmacol., January 1, 2007; 71(1): 250 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. O. Ward, D. A. Delker, S. D. Hester, S.-F. Thai, D. C. Wolf, J. W. Allen, and S. Nesnow Transcriptional Profiles in Liver from Mice Treated with Hepatotumorigenic and Nonhepatotumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil Toxicol Pathol, December 1, 2006; 34(7): 863 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Osanai, M. Murata, N. Nishikiori, H. Chiba, T. Kojima, and N. Sawada Epigenetic Silencing of Occludin Promotes Tumorigenic and Metastatic Properties of Cancer Cells via Modulations of Unique Sets of Apoptosis-Associated Genes. Cancer Res., September 15, 2006; 66(18): 9125 - 9133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Shelton, I. T. Sandoval, A. Eisinger, S. Chidester, A. Ratnayake, C. M. Ireland, and D. A. Jones Up-regulation of CYP26A1 in Adenomatous Polyposis Coli-Deficient Vertebrates via a WNT-Dependent Mechanism: Implications for Intestinal Cell Differentiation and Colon Tumor Development. Cancer Res., August 1, 2006; 66(15): 7571 - 7577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Hoffman, K. Garcha, K. Karamboulas, M. F. Cowan, L. M. Drysdale, W. A. Horton, and T. M. Underhill BMP action in skeletogenesis involves attenuation of retinoid signaling J. Cell Biol., July 3, 2006; 174(1): 101 - 113. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
